Glenmark Pharmaceuticals is currently trading at Rs. 867.00, up by 31.85 points or 3.81% from its previous closing of Rs. 835.15 on the BSE.
The scrip opened at Rs. 835.15 and has touched a high and low of Rs. 870.50 and Rs. 828.00 respectively. So far 1,47,000 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1261.95 on 21-Aug-2015 and a 52 week low of Rs. 671.50 on 12-Feb-2016.
Last one week high and low of the scrip stood at Rs. 875.00 and Rs. 821.45 respectively. The current market cap of the company is Rs. 24,541.00 crore.
The promoters holding in the company stood at 46.48%, while Institutions and Non-Institutions held 42.06% and 11.46% respectively.
The company has registered 53.23% jump in its net profit at Rs 518.81 crore for first quarter ended June 30, 2016 as compared to Rs 338.57 crore for the same quarter in the previous year. Total income of the company increased by 36.50 % at Rs 1738.80 crore for quarter under review as compared to Rs 1273.85 crore for the quarter ended June 30, 2015.
On the consolidated basis, the company has reported 23.96% jump in its net profit after taxes, minority interest and share of profit of associates at Rs 226.78 crore for the quarter ended June 30, 2016 as compared to Rs 182.95 crore for the same quarter in the previous year. However, total Income of the company increased by 22.13% to Rs 2018.97 crore for quarter under review from Rs 1653.11 crore for the quarter ended June 30, 2015.